Skip Navigation
Skip to contents

Anat Cell Biol.  2011 Dec;44(4):245-255. 10.5115/acb.2011.44.4.245.

Induced pluripotent stem cells and personalized medicine: current progress and future perspectives

Affiliations
  • 1Department of Surgery, Gachon University Gil Hospital, Incheon, Korea. chunysmd@gmail.com
  • 2Department of Anatomy and Cell Biology, Gachon University, Incheon, Korea.
  • 3Center for Regenerative Medicine, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea.

Abstract

Generation of induced pluripotent stem cells (iPSCs) has revolutionized the field of regenerative medicine by providing researchers with a unique tool to derive disease-specific stem cells for study. iPSCs can self-renew and can differentiate into many cell types, offering a potentially unlimited source of cells for targeted differentiation into somatic effector cells. Hence, iPSCs are likely to be invaluable for therapeutic applications and disease-related research. In this review, we summarize the recent progress of iPSC generation that has been made with an emphasis on both basic and clinical applications including disease modeling, drug toxicity screening/drug discovery and cell replacement therapy.

Keyword

Induced pluripotent stem cell; Disease modeling; Genomics; Proteomics

MeSH Terms

Drug Design
Genomics
Humans
Induced Pluripotent Stem Cells
Proteomics
Regenerative Medicine
Stem Cells
Full Text Links
  • ACB
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr